Resideo Technologies REZI 深 沪
等待开盘 07-18 09:30:00 美东时间
24.21
+0.820
+3.51%
华盛通- 最 高24.44
- 今 开23.38
- 成交量 122.98万股
- 最 低 23.38
- 昨 收 23.39
- 总市值 36.07亿
- 52周最高 28.28
- 市盈率 静 39.64
- 换手率 0.83%
- 52周最低 14.18
- 委 比 62.96%
- 总股本 1.49亿
- 历史最高 33.25
- 量 比 1.42
- 振 幅 4.53%
- 历史最低 3.72
- 每 手 1
- 风险率 2.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅417.8%！RBC Capital上调Perspective Therapeutics目标价至16美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136940401951563776.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• RBC Capital：维持Perspective Therapeutics(CATX)"跑赢大市"评级，目标价从15美元升至16美元</p> <p>• Canaccord Genuity：维持Taysha Gene Th
06-04 08:35
Reported Sunday, Taiho And Cullinan's Zipalertinib Shows 40% ORR In Platinum-Treated EGFR ex20ins NSCLC, REZILIENT1 Results Published In JCO
Highlights of the REZILIENT1 Phase 1/2 trial in the authors' conclusions include:Zipalertinib demonstrated clinically meaningful efficacy in the primary efficacy population (n=176), including 51 patients who had received
06-02 15:31
Cullinan Therapeutics And Taiho To Present Phase 2b Results From REZILIENT1 Trial Of Zipalertinib In Previously Treated EGFR ex20ins NSCLC At ASCO 2025
Cullinan Therapeutics, Inc. (NASDAQ:CGEM), Taiho Pharmaceutical Co., Ltd., and Taiho Oncology, Inc. today announced new positive results from the pivotal Phase 2b cohorts of the REZILIENT1 trial, a Phase 1/2
05-23 05:33
Rockwell Automation Posts Better-Than-Expected Earnings, Joins Oscar Health, Charles River Laboratories, Walt Disney, Voya Financial And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on ...
05-07 22:10
Resideo To Participate at Upcoming Investor Conferences
SCOTTSDALE, Ariz., May 5, 2025 /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls pr...
05-06 04:05
Resideo to Release First Quarter 2025 Financial Results on May 6, 2025
SCOTTSDALE, Ariz., April 15, 2025 /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls...
04-16 04:05
Teradata rises after Morgan Stanley upgrades on valuation benefit
Morgan Stanley upgraded Teradata (NYSE:TDC) to Overweight from Equal-weight while revising price targets on several IT hardware stocks. The firm reduced the price target to $26 from $29 on the shares ...
04-08 20:44
First Alert and Google Nest Announce Connected Life-Safety Partnership
New First Alert Smart Smoke & CO Alarm compatible with Google Home ecosystem and designed for seamless integration with Nest Protect Smart Smoke & CO Alarm SCOTTSDALE, Ariz., March 28, 2025 ...
03-28 23:00
Adapt Or Get Left Behind: JPMorgan's Top Stocks For A Hotter World
JPMorgan highlights 157 stocks poised for climate adaptation, with 75 Overweight ratings. Report encourages investors to consider opportunities.
02-26 23:53
